Male infertility

Summary

It is estimated that infertility affects 8–12% of couples globally, with a male factor being a primary or contributing cause in approximately 50% of couples. Causes of male subfertility vary highly, but can be related to congenital, acquired, or idiopathic factors that impair spermatogenesis. Many health conditions can affect male fertility, which underscores the need for a thorough evaluation of patients to identify treatable or reversible lifestyle factors or medical conditions. Although semen analysis remains the cornerstone for evaluating male infertility, advanced diagnostic tests to investigate sperm quality and function have been developed to improve diagnosis and management. The use of assisted reproductive techniques has also substantially improved the ability of couples with infertility to have biological children. This Seminar aims to provide a comprehensive overview of the assessment and management of men with infertility, along with current controversies and future endeavours.

Introduction

WHO defines infertility as the inability to conceive after at least 12 months of regular, unprotected sexual intercourse.¹ Infertility is a major health problem worldwide and is estimated to affect 8–12% of couples in the reproductive age group.² A Global Burden of Disease survey reported that between 1990 and 2017, the age-standardised prevalence of infertility increased annually by 0·370% in women and by 0·291% in men.³

Infertility causes substantial psychological and social distress,4, 5 and imposes a considerable economic burden on patients and health-care systems.⁶ Early diagnosis and appropriate management can mitigate these factors. In a prospective study of 384 419 Danish men, Glazer and colleagues⁷ reported a higher risk of mortality among men with male factor infertility than among men who were fertile. Ventimiglia and colleagues⁸ showed that impaired male reproductive health (including poorer semen parameters and lower testosterone levels) was associated with a higher Charlson Comorbidity Index, which is a proxy of decreased general health status.⁹ Severe male infertility is also associated with a greater incidence of cancer.¹⁰ Thus, early detection of male subfertility offers the opportunity for identification and correction of medical conditions affecting not only fertility, but also general health and wellbeing.¹¹

There is increasing evidence that paternal health at the time of conception can affect the offspring's metabolic health and reproductive potential, through transgenerational transmission of epigenetic modifications.¹² Thus, obesity or diabetes¹³ might contribute not only to male subfertility, but can also compromise the health of future progeny. A study of 744 men with infertility revealed that 15·4% of men who met the criteria suggestive of prediabetes were at increased risk of hypogonadism, higher sperm DNA fragmentation, and non-obstructive azoospermia.¹⁴ Men who are oligozoospermic are more likely to have metabolic syndrome than men who are normozoospermic.¹⁵ Therefore, it is important to look beyond a semen analysis, and to view male infertility as a condition connected to and promoting a state of impaired metabolism.

The cause of infertility lies solely with the man in 20–30% of cases and a male cause is contributory in a further 20%.16, 17 In 1992, a large meta-analysis by Carlsen and colleagues confirmed that sperm counts had declined by 50% during a 60-year period.¹⁸ Subsequently, numerous studies have shown similar declines globally,19, 20 although some studies have disputed this claim.21, 22 A systematic review by Levine and colleagues²³ reported that sperm counts decreased by 50–60% between 1973 and 2011.

We searched Scopus and PubMed for relevant articles on male infertility using the search term “male infertility” in combination with the search terms “epidemiology”, “etiology”, “pathophysiology”, “investigations”, “azoospermia”, “oligoasthenoteratozoospermia”, “asthenozoospermia”, “varicocele”, “genetic abnormalities”, “cryptorchidism”, “testicular cancer”, “obstruction”, “hypogonadism”, “ejaculatory dysfunction”, “idiopathic”, “risk factors”, “diagnosis”, “clinical evaluation”, “sperm DNA fragmentation index”, “reactive oxygen species”, “genetic testing”, “imaging”, “management”, “treatment”, “antioxidant therapy”, “varicocelectomy”, “ART”, or “omics”. We selected articles mostly published in the past 5 years and highly cited older publications. We also reviewed the reference list of the retrieved articles and selected articles that discussed male infertility, were published within the last 5 years, and were not retrieved in the initial search. Highly referenced reviews and book chapters are cited to provide readers with more information and references than this Seminar can accommodate.

The causes of male subfertility are wide ranging and poorly understood in most cases.24, 25, 26 Although various diagnostic tests are available, their interpretation is imprecise and often subjective.²⁷ Intracytoplasmic sperm injection has made it possible to achieve pregnancy with very poor semen quality—eg, in cases of azoospermia for which surgically retrieved testicular sperm are used.²⁸ Exciting new therapies using stem cells and in-vitro sperm maturation are still experimental. This Seminar aims to review our current understanding of these issues and provide practice guidelines for individualising and optimising the management of men with subfertility.